subject
Business, 16.10.2019 03:10 fedora87

Drampharma is a company that manufactures and sells medicine to treat huntington's disease, a rare genetic disorder. the company controls 80 percent of the world's industry in its segment. the company aims to seek steady growth in the industry. in terms of adaptive strategies, drampharma would most likely be categorized as a(n)

ansver
Answers: 1

Other questions on the subject: Business

image
Business, 22.06.2019 12:30, ash011519
On june 1, 2017, blossom company was started with an initial investment in the company of $22,360 cash. here are the assets, liabilities, and common stock of the company at june 30, 2017, and the revenues and expenses for the month of june, its first month of operations: cash $4,960 notes payable $12,720 accounts receivable 4,340 accounts payable 840 service revenue 7,860 supplies expense 1,100 supplies 2,300 maintenance and repairs expense 700 advertising expense 400 utilities expense 200 equipment 26,360 salaries and wages expense 1,760 common stock 22,360 in june, the company issued no additional stock but paid dividends of $1,660. prepare an income statement for the month of june.
Answers: 3
image
Business, 23.06.2019 01:00, F00Dislife
What are the benefits of different types of career education, like community colleges, vocational training programs, and four-year colleges?
Answers: 3
image
Business, 23.06.2019 08:00, ibrahimharoon
Wriston company is preparing its cash budget for the upcoming month. the beginning cash balance for the month is expected to be $15,000. budgeted cash disbursements are $72,500, while budgeted cash receipts are $89,600. wriston company wants to have an ending cash balance of $30,000. the excess (deficiency) of cash available over disbursements for the month would be
Answers: 2
image
Business, 23.06.2019 10:00, dani595
Bagwell's net income for the year ended december 31, year 2 was $189,000. information from bagwell's comparative balance sheets is given below. compute the cash received from the sale of its common stock during year 2. at december 31 year 2 year 1 common stock, $5 par value $ 504,000 $ 453,600 paid-in capital in excess of par 952,000 856,600 retained earnings 692,000 585,600
Answers: 3
You know the right answer?
Drampharma is a company that manufactures and sells medicine to treat huntington's disease, a rare g...

Questions in other subjects:

Konu
Mathematics, 14.09.2020 08:01
Konu
History, 14.09.2020 08:01
Konu
History, 14.09.2020 08:01
Konu
Mathematics, 14.09.2020 08:01
Konu
Biology, 14.09.2020 08:01
Konu
Social Studies, 14.09.2020 08:01
Konu
Mathematics, 14.09.2020 08:01
Konu
Mathematics, 14.09.2020 08:01
Konu
Mathematics, 14.09.2020 08:01
Konu
Mathematics, 14.09.2020 08:01